LBT Innovations Limited (ASX:LBT) Insider Purchases A$33,993.50 in Stock

LBT Innovations Limited (ASX:LBT) insider Rebecca Wilson acquired 6,798,700 shares of the company’s stock in a transaction that occurred on Thursday, June 27th. The stock was bought at an average price of A$0.01 ($0.00) per share, with a total value of A$33,993.50 ($22,662.33).

LBT Innovations Price Performance

The company has a debt-to-equity ratio of 129.00, a quick ratio of 2.10 and a current ratio of 4.51.

About LBT Innovations

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring.